Pharmacokinetics, Safety and Tolerability of Aliskiren (SPP100) in Patients With End Stage Renal Disease on Hemodialysis and Matched Healthy Subjects
Condition(s):End Stage Renal DiseaseLast Updated:April 2, 2012Completed
Hide Studies Not Open or Pending
Condition(s):End Stage Renal DiseaseLast Updated:April 2, 2012Completed
Condition(s):End-stage Renal Disease (ESRD)Last Updated:December 13, 2016Completed
Condition(s):End Stage Renal DiseaseLast Updated:April 18, 2018Completed
Condition(s):Restless Legs Syndrome; End Stage Renal DiseaseLast Updated:August 24, 2022Not yet recruiting
Condition(s):Hemodialysis; HealthyLast Updated:July 24, 2019Completed
Condition(s):End-Stage Kidney Disease; Hemolysis; NursingLast Updated:July 11, 2018Completed
Condition(s):End Stage Renal DiseaseLast Updated:November 4, 2012Unknown status
Condition(s):Renal Insufficiency, ChronicLast Updated:January 8, 2016Unknown status
Condition(s):End Stage Kidney Disease; Fibrosis MyocardialLast Updated:October 3, 2023Recruiting
Condition(s):Patients With End Stage Renal Disease on HemodialysisLast Updated:May 12, 2023Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.